| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director | 10% Owner +3 more
10 companies
Fairmount Funds Management LLC is a Director at COGT, with reported holdings spanning 10 companies. Recent filings cover 22 purchases and 4 sales. Those positions are worth an estimated $489.6M at current prices.
Our model assigns Fairmount Funds Management LLC a strong insider score of 74/100, based on 18 past trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +53.5%.
Fairmount Funds Management LLC's largest disclosed position is in COGT as Director, worth about $190.7M. The recent filings there lean toward selling, a net 5,722,223 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | CBIO Crescent Biopharma, Inc. | Director, 10% Owner | Buy | 853,450 | $14.50 | $12,375,025.00 | +31.1% | -16.7% | - | |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Director, 10% Owner | Sell | 3,553,410 | $84.43 | $300,014,406.30 | -75.8% | -11.9% | - | |
| Jun 23, 2026 | SYRE Spyre Therapeutics, Inc. | Director | Sell | 4,684,781 | $85.31 | $399,658,667.11 | -100% | -5.2% | - | |
| May 11, 2026 | VRDN Viridian Therapeutics, Inc. | Director, 10% Owner | Buy | 1,176,470 | $17.00 | $19,999,990.00 | +30.1% | +34.1% | - | |
| Mar 31, 2026 | COGT Cogent Biosciences, Inc. | Director | Sell | 7,000,000 | $34.66 | $242,620,000.00 | -56.0% | +0.6% | - | |
| Mar 31, 2026 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 150,000 | $20.00 | $3,000,000.00 | +6.8% | +30.7% | - | |
| Jan 22, 2026 | COGT Cogent Biosciences, Inc. | Director | Sell | 3,500,000 | $36.40 | $127,400,000.00 | -38.9% | -7.9% | - | |
| Dec 4, 2025 | CBIO Crescent Biopharma, Inc. | Director, 10% Owner | Buy | 1,360,000 | $13.41 | $18,237,600.00 | +98.0% | -11.5% | - | |
| Oct 23, 2025 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner | Buy | 454,545 | $22.00 | $9,999,990.00 | +13.1% | +46.3% | +1.4% | |
| Oct 7, 2025 | ZBIO Zenas Biopharma, Inc. | Director | Buy | 316,219 | $19.00 | $6,008,161.00 | +16.7% | -20.3% | +35.2% |